Senior Director, Global Forecasting

Revolution Medicines•Redwood City, CA
•$244,000 - $305,000•Hybrid

About The Position

The Senior Director, Global Forecasting reports directly to the Executive Director, Global Forecasting, and provides strategic contributions to disease-area strategy, life-cycle planning, and product and portfolio decisions. The role acts as a cross-functional strategic thought partner, developing, refining, and communicating strategic and revenue forecast assumptions and analyses to inform portfolio investment and life-cycle strategy decisions. It works with Global and Regional Forecasting leads to maintain consistency in forecasting approaches, assumptions, and analyses. The role leads forecasters developing and maintaining global forecasts for a tumor type, integrating forecasts to assess interactions across products, indications, and the broader portfolio. It addresses complex relationships among products and indications within and across tumor types and translates forecast scenarios into actionable insights for long-range planning, supply planning, and go/no-go decisions. The position works closely with Global Commercial Development, Clinical Development, Portfolio Strategy, Finance, Medical Affairs, regional and local teams, and vendor partners. The position is ideally based at Revolution Medicines’ Redwood City, California headquarters, but remote candidates may be considered if they are willing to travel regularly to the California office. Domestic and international travel is typically up to 25–30%.

Requirements

  • Bachelor’s degree required; MBA preferred.
  • 12+ years of progressive experience in pharmaceutical, biotechnology, or strategic consulting roles, including 8+ years in a related forecasting role.
  • Experience developing long-range patient-based oncology forecasts and complex scenarios involving interactions among multiple products and indications within the same tumor type and across a portfolio.
  • Experience translating forecast uncertainty and portfolio scenarios into insights for long-range planning, supply planning, investment prioritization, and go/no-go decisions.
  • Experience developing and supporting early-stage forecasting; comfort with ambiguity, uncertainty, and rapidly evolving information and priorities.
  • Experience working with global, regional, and local teams to establish shared forecasting approaches, explain material differences, and provide analytical support tailored to local needs and capabilities.
  • Collaborative and adaptive approach suited to a growing business.
  • Strong problem-solving skills and experience using varied research and analytical vendors and study designs, and building quality research vendor partnerships.
  • Demonstrated ability to influence senior management and key business partners.
  • Proven experience in a smaller, rapidly growing company.
  • Excellent organizational skills and ability to prioritize and deliver within reasonably established timelines.
  • Strong interpersonal, verbal, and written communication skills, and ability to represent Revolution Medicines well.
  • Entrepreneurial mindset, tolerance for ambiguity, and passion for helping cancer patients.

Nice To Haves

  • MBA.
  • 8+ years of patient-based forecasting experience with a focus in Oncology.
  • Experience with targeted Oncolytics.
  • Experience managing teams.
  • Demonstrated ability to synthesize complex information and influence decision-making at the executive level.

Responsibilities

  • Lead a team of forecasters responsible for developing and maintaining global forecast models for a tumor type and integrating forecasts to assess interactions across products, indications, and the broader portfolio.
  • Ensure alignment with Global forecasting standards and governance; partner with global and regional forecasting leads to establish and maintain shared methodologies, core assumptions, scenario definitions, and forecast reviews while accommodating justified market differences.
  • Develop and maintain patient-based forecasts and complex scenarios across indications and the portfolio, assessing treatment sequencing, overlapping eligible populations, combinations, launch timing, and substitution or complementary use to quantify incremental opportunity and avoid double counting patients and demand.
  • Communicate and align internal stakeholders around key forecast assumptions.
  • Understand complex markets, disease states, competitive landscapes, and market and managed-care dynamics to develop strategic forecasts and plans.
  • Synthesize and communicate similarities, differences, and considerations that inform Global clinical development plans.
  • Conduct opportunity assessments, sensitivity analyses, and risk quantification to clarify uncertainties, interdependencies, and decision thresholds for portfolio prioritization, investment, and go/no-go decisions; partner with Portfolio Strategy to develop processes and systems.
  • Partner with the forecasting team, Finance, Supply Chain, and cross-functional teams to translate patient, treatment-duration, and utilization assumptions into revenue and demand scenarios for long-range plans, budgets, supply and capacity planning, and launch readiness; communicate forecast ranges, risks, and changes.
  • Partner with Disease Area Insights, Data Analytics, and other Insights and Analytics functions to inform forecasts.
  • Work with Global Commercial Development, Clinical Development, Portfolio Strategy, Finance, and Medical Affairs to support early-stage decision-making.
  • Work with regional teams to ensure consistency; explain forecast differences, document and reconcile material differences in assumptions, methods, and outputs, and communicate their rationale and implications for global and regional planning.
  • Provide forecasting expertise, tools, and hands-on analytical support to regional and local teams, adapting support to local capabilities and priorities; help teams apply shared frameworks, build capabilities, and share insights and effective practices.
  • Maintain an in-depth understanding of the company’s product offerings, competitive positioning, and broader market dynamics.
  • Collaborate with vendor partners to manage deliverables and analyses.
  • Travel domestically and internationally as needed, typically up to 25–30%.

Benefits

  • Competitive cash compensation.
  • Robust equity awards.
  • Strong benefits.
  • Significant learning and development opportunities.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service